4.5 Article

G protein-coupled estrogen receptor-mediated effects on cytosolic calcium and nanomechanics in brain microvascular endothelial cells

期刊

JOURNAL OF NEUROCHEMISTRY
卷 133, 期 5, 页码 629-639

出版社

WILEY
DOI: 10.1111/jnc.13066

关键词

atomic force microscopy; blood-brain barrier; calcium signaling; cerebral microvasculature; GPER

资金

  1. Jefferson School of Pharmacy
  2. NIH from the Department of Health and Human Services [P30 DA 013429]

向作者/读者索取更多资源

G protein-coupled estrogen receptor (GPER) is a relatively recently identified non-nuclear estrogen receptor, expressed in several tissues, including brain and blood vessels. The mechanisms elicited by GPER activation in brain microvascular endothelial cells are incompletely understood. The purpose of this work was to assess the effects of GPER activation on cytosolic Ca2+ concentration, [Ca2+](i), nitric oxide production, membrane potential and cell nanomechanics in rat brain microvascular endothelial cells (RBMVEC). Extracellular but not intracellular administration of G-1, a selective GPER agonist, or extracellular administration of 17--estradiol and tamoxifen, increased [Ca2+](i) in RBMVEC. The effect of G-1 on [Ca2+](i) was abolished in Ca2+-free saline or in the presence of a L-type Ca2+ channel blocker. G-1 increased nitric oxide production in RBMVEC; the effect was prevented by NG-nitro-l-arginine methyl ester. G-1 elicited membrane hyperpolarization that was abolished by the antagonists of small and intermediate-conductance Ca2+-activated K+ channels, apamin, and charibdotoxin. GPER-mediated responses were sensitive to G-36, a GPER antagonist. In addition, atomic force microscopy studies revealed that G-1 increased the modulus of elasticity, indicative of cytoskeletal changes and increase in RBMVEC stiffness. Our results unravel the mechanisms underlying GPER-mediated effects in RBMVEC with implications for the effect of estrogen on cerebral microvasculature.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Neurosciences

Pharmacologic Inhibition of 5-Lipoxygenase Improves Memory, Rescues Synaptic Dysfunction, and Ameliorates Tau Pathology in a Transgenic Model of Tauopathy

Phillip F. Giannopoulos, Jin Chu, Margaret Sperow, Jian-Guo Li, W. Haung Yu, Lynn G. Kirby, Mary Abood, Domenico Pratico

BIOLOGICAL PSYCHIATRY (2015)

Article Cell Biology

Mechanisms of activation of nucleus accumbens neurons by cocaine via sigma-1 receptor-inositol 1,4,5-trisphosphate-transient receptor potential canonical channel pathways

Jeffrey L. Barr, Elena Deliu, G. Cristina Brailoiu, Pingwei Zhao, Guang Yan, Mary E. Abood, Ellen M. Unterwald, Eugen Brailoiu

CELL CALCIUM (2015)

Article Substance Abuse

HIV-gp120 and physical dependence to buprenorphine

J. Palma, M. E. Abood, K. Benamar

DRUG AND ALCOHOL DEPENDENCE (2015)

Editorial Material Chemistry, Medicinal

Allosteric Modulators: A Side Door

Mary E. Abood

JOURNAL OF MEDICINAL CHEMISTRY (2016)

Article Pharmacology & Pharmacy

Activation of GPR18 by cannabinoid compounds: a tale of biased agonism

Linda Console-Bram, Eugen Brailoiu, Gabriela Cristina Brailoiu, Haleli Sharir, Mary E. Abood

BRITISH JOURNAL OF PHARMACOLOGY (2014)

Article Biochemistry & Molecular Biology

Allosteric Modulation of a Cannabinoid G Protein-coupled Receptor BINDING SITE ELUCIDATION AND RELATIONSHIP TO G PROTEIN SIGNALING

Derek M. Shore, Gemma L. Baillie, Dow H. Hurst, Frank Navas, Herbert H. Seltzman, Jahan P. Marcu, Mary E. Abood, Ruth A. Ross, Patricia H. Reggio

JOURNAL OF BIOLOGICAL CHEMISTRY (2014)

Article Biochemistry & Molecular Biology

Crucial Positively Charged Residues for Ligand Activation of the GPR35 Receptor

Pingwei Zhao, Tom R. Lane, Helen G. L. Gao, Dow P. Hurst, Evangelia Kotsikorou, Long Le, Eugen Brailoiu, Patricia H. Reggio, Mary E. Abood

JOURNAL OF BIOLOGICAL CHEMISTRY (2014)

Article Chemistry, Medicinal

CB2-Selective Cannabinoid Receptor Ligands: Synthesis, Pharmacological Evaluation, and Molecular Modeling Investigation of 1,8-Naphthyridin-2(1H)-one-3-carboxamides

Valentina Lucchesi, Dow P. Hurst, Derek M. Shore, Simone Bertini, Brandie M. Ehrmann, Marco Allara, Lyle Lawrence, Alessia Ligresti, Filippo Minutolo, Giuseppe Saccomanni, Haleli Sharir, Marco Macchia, Vincenzo Di Marzo, Mary E. Abood, Patricia H. Reggio, Clementina Manera

JOURNAL OF MEDICINAL CHEMISTRY (2014)

Article Multidisciplinary Sciences

The Two-pore channel (TPC) interactome unmasks isoform-specific roles for TPCs in endolysosomal morphology and cell pigmentation

Yaping Lin-Moshier, Michael V. Keebler, Robert Hooper, Michael J. Boulware, Xiaolong Liu, Dev Churamani, Mary E. Abood, Timothy F. Walseth, Eugen Brailoiu, Sandip Patel, Jonathan S. Marchant

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)

Article Chemistry, Medicinal

Therapeutic Exploitation of GPR18: Beyond the Cannabinoids? Miniperspective

Paula Morales, Ana Lago-Fernandez, Dow P. Hurst, Noori Sotudeh, Eugen Brailoiu, Patricia H. Reggio, Mary E. Abood, Nadine Jagerovic

JOURNAL OF MEDICINAL CHEMISTRY (2020)

Article Pharmacology & Pharmacy

The NPXXY Motif Regulates β-Arrestin Recruitment by the CB1 Cannabinoid Receptor

Luciana M. Leo, Rufaida Al-Zoubi, Dow P. Hurst, Anna P. Stephan, Pingwei Zhao, Douglas G. Tilley, Elke Miess, Stefan Schulz, Mary E. Abood, Patricia H. Reggio

Summary: This study discovered the crucial role of amino acids in the NPXXY motif of the CB1 receptor in beta-arrestin recruitment. These findings reveal a novel mechanism for beta-arrestin recruitment and suggest the significance of amino acids in the NPXXY motif in the specific conformational state of GPCRs.

CANNABIS AND CANNABINOID RESEARCH (2023)

Article Pharmacology & Pharmacy

Contribution of G Protein-Coupled Receptor 55 to Periaqueductal Gray-Mediated Antinociception in the Inflammatory Pain

Henry Blanton, Sabiha Armin, Steven Muenster, Mary Abood, Khalid Benamar

Summary: This study found that blockade of GPR55 action in the periaqueductal gray can alleviate inflammatory pain, suggesting an important role of GPR55 in the descending pain modulatory system.

CANNABIS AND CANNABINOID RESEARCH (2022)

Article Biochemistry & Molecular Biology

Identification of Crucial Amino Acid Residues Involved in Agonist Signaling at the GPR55 Receptor

Mary A. Lingerfelt, Pingwei Zhao, Haleli P. Sharir, Dow P. Hurst, Patricia H. Reggio, Mary E. Abood

BIOCHEMISTRY (2017)

Article Pharmacology & Pharmacy

The Lysophosphatidylinositol Receptor GPR55 Modulates Pain Perception in the Periaqueductal Gray

Elena Deliu, Margaret Sperow, Linda Console-Bram, Rhonda L. Carter, Douglas G. Tilley, Daniel J. Kalamarides, Lynn G. Kirby, G. Cristina Brailoiu, Eugen Brailoiu, Khalid Benamar, Mary E. Abood

MOLECULAR PHARMACOLOGY (2015)

Article Biochemistry & Molecular Biology

Associations between liver function and cerebrospinal fluid biomarkers of Alzheimer's disease pathology in non-demented adults: The CABLE study

Pei-Yang Gao, Ya-Nan Ou, Yi-Ming Huang, Zhi-Bo Wang, Yan Fu, Ya-Hui Ma, Qiong-Yao Li, Li-Yun Ma, Rui-Ping Cui, Yin-Chu Mi, Lan Tan, Jin-Tai Yu

Summary: Liver function may play a role in the progression of Alzheimer's disease. The study found that as AD progressed, certain liver function markers increased while others decreased. The relationship between liver function and CSF AD biomarkers indicates a potential mediation effect on cognition.

JOURNAL OF NEUROCHEMISTRY (2024)